The Role of Exosomes in Lysosomal Storage Disorders

Abstract

Exosomes, small membrane-bound organelles formed from endosomal membranes, represent a heterogenous source of biological and pathological biomarkers capturing the metabolic status of a cell. Exosomal cargo, including lipids, proteins, mRNAs, and miRNAs, can either act as inter-cellular messengers or are shuttled for autophagic/lysosomal degradation. Most cell types in the central nervous system (CNS) release exosomes, which serve as long and short distance communicators between neurons, astrocytes, oligodendrocytes, and microglia. Lysosomal storage disorders are diseases characterized by the accumulation of partially or undigested cellular waste. The exosomal content in these diseases is intrinsic to each individual disorder. Emerging research indicates that lysosomal dysfunction enhances exocytosis, and hence, in lysosomal disorders, exosomal secretion may play a role in disease pathogenesis. Furthermore, the unique properties of exosomes and their ability to carry cargo between adjacent cells and organs, and across the blood–brain barrier, make them attractive candidates for use as therapeutic delivery vehicles. Thus, understanding exosomal content and function may have utility in the treatment of specific lysosomal storage disorders. Since lysosomal dysfunction and the deficiency of at least one lysosomal enzyme, glucocerebrosidase, is associated with the development of parkinsonism, the study and use of exosomes may contribute to an improved understanding of Parkinson disease, potentially leading to new therapeutics.

The Expression of miR-205 in Prostate Carcinoma and the Relationship with Prognosis in Patients

“…Exosomes are vesicles present outside the cell. They have a diameter of 30-150 nm and lipid bilayer membrane, which are mostly found in numerous body liquids [ 21 , 22 ]. The main substances of exosomes include proteins, nucleic acids, and lipids.…”

Hypomyelinating Leukodystrophy 7 (HLD7)-Associated Mutation of POLR3A Is Related to Defective Oligodendroglial Cell Differentiation, Which Is Ameliorated by Ibuprofen

“…It is thought that dynamic morphological changes are usually accomplished with RNA production and, in turn, protein synthesis. Another reason may be that oligodendrocyte RNA polymerase III participates in synthesizing small RNA(s), such as oligodendrocyte-specific miRNAs [ 37 , 38 ]. In either case, it is noteworthy that dynamic morphological changes in oligodendrocytes are very different from those in other cells, possibly utilizing many RNAs.…”

Potential Application of Exosomes in Vaccine Development and Delivery

“…Under inflammation or stress conditions, cells remove modified fragmented via released exosome (249). Also, exosomes do not release cargo in the blood without distant and neighboring cells (250). Therefore, blood is not infected due to disease cell-derived exosome.…”